Observational Study of Pacing Therapy for Atrial Tachycardia in Congenital Heart Disease
This study is looking at how well Medtronic pacing devices work to manage atrial tachycardia (a fast, irregular heartbeat) in people with congenital heart disease (heart problems present at birth). Researchers will review existing medical records to see if the pacing therapy, delivered by an implanted device, changes the amount of atrial arrhythmia (irregular heartbeats) over at least five years. You could be eligible if you have structural congenital heart disease, an atrial arrhythmia, and an implanted Medtronic device with its pacing therapy turned on. The study is currently recruiting participants by reviewing existing patient data, aiming for 250 to 300 individuals.
- Study design
- This is an observational study, meaning researchers will review existing medical records rather than conducting new interventions. The study aims to include 250 to 300 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' medical records will be reviewed to measure changes in atrial arrhythmia over a minimum of five years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
ATrial Tachycardia PAcing Therapy in Congenital Heart
At a glance
Conditions
NCT03209583
Where you'd take part
This study runs at 15 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Baylor College of Medicine
Houston, Texasstudy coordinator listed
Recruiting
University of Iowa Children's Hospital
Iowa City, Iowastudy coordinator listed
Recruiting
Children's Hospital of Michigan
Detroit, Michiganno site contact published
Recruiting
Children's Hospital of Orange County (CHOC)
Orange, Californiano site contact published
Recruiting
Indiana University Health
Indianapolis, Indianano site contact published
Not yet recruiting
Mayo Clinic
Rochester, Minnesotano site contact published
Not yet recruiting
Memorial Healthcare System
Hollywood, Floridano site contact published
Not yet recruiting
Norton Healthcare
Louisville, Kentuckyno site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- To measure any change in IART burden before and after ATD implantation.5 years at minimum
The comparison will be how many times a cardioversion was needed and or how many times the device was able to or wasn't able to pace the heart out of the fast rate which could otherwise have been treated with a cardioversion. Data will be collected for a maximum of 5 years prior to implantation of an ATD and compared to a maximum of 5 years post implantation.